Dr. Bähler Wallwurzgel, Gel

7680607190019 CH-60719 Gel
Dr. Bähler Wallwurzgel, Gel
Dr. Bähler Wallwurzgel, Gel
Dr. Bähler Wallwurzgel, Gel
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/10/2022
Patient information leaflet
Français
18/10/2022
Patient information leaflet
Italien
18/10/2022

Detailed composition

Substance Quantity Type Category
(N/A)
350.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
330.0 MG Substance HBESI

Authorization holder

DR. BÄHLER DROPA AG

8045 Zürich

Authorization information

Swissmedic authorization number
60719
Drug name
Dr. Bähler Wallwurzgel, Gel
Galenic form
GELK
ATC Code
M02AX10
Authorization status
Z
Authorization category
Category C
Dispensing category
D
First authorization
16/10/2009
Authorization expiration date
31/12/9999
IT Number
07.10.4.
Domain
Human medicine
Field of application
Bei stumpfen Verletzungen und zur unterstützenden Behandlung bei rheumatischen Beschwerden

Package details

Description (FR)
DR. BÄHLER gel de consoude tb 100 g
Description (DE)
DR. BÄHLER Wallwurzgel Tb 100 g
Market launch
16/10/2009
Narcotic (BTM)
No